| Evotec–Berenberg: investor conference, 201712 supply service Evotec presents at Berenberg European Conference in Surrey |
2017-12-06 |
| Novartis–Medigene: Veregen, 201712– acquisition €na of US rights to Veregen by Fougera Pharmaceuticals Inc |
2017-12-05 |
| Probiodrug–Crossbeta Biosciences: biomarker research, 201712– collab extension developm Alzheimer biomarker to support Probiodrug’s clinical program |
2017-12-05 |
| Probiodrug–MC Services: public relations, 201712 service existent by MC Services |
2017-12-05 |
| Probiodrug–Optimum Strategic Communications: public relations, 201712 service existent by Optimum |
2017-12-05 |
| Probiodrug–Trout Group: public relations, 201712 service existent by The Trout Group |
2017-12-05 |
| Evotec–Ncardia: drug discovery technology, 201712– license ww non-excl €na to access iPSC-derived disease models of Ncardia |
2017-12-04 |
| Institut Virion\Sirion–ExpreS2ion Biotech: expression technology, 201712– collab using ExpreS2 platform for antigen production for IVD tests |
2017-12-04 |
| I-Mab–MorphoSys: antibody cancer drug, 201711– license excl Greater China for MOR202 with $20m upfront + $100m milestones + tiered 2-digit royalties |
2017-11-30 |
| Abivax–Deutsche Börse: investor conference, 201711 supply service Abivax presents at Deutsches Eigenkapitalforum 2017 |
2017-11-28 |
| Bitkom–Bayer: digital economy, 201711 Bayer is member of Bitkom w particular focus on digital health + digital farming |
2017-11-27 |
| Boehringer–BioMed X: pharma research, 201711– collab new BioMed X research group in bacterial modulation of innate immunity |
2017-11-27 |
| Evotec–Deutsche Börse: investor conference, 201711 supply service Evotec AG presents at Deutsches Eigenkapitalforum 2017 |
2017-11-27 |
| Evotec–Volks- und Raiffensenbanken (DE): investor conference, 201711 supply service Evotec attends DZ Bank Equity Conference 2017 in Ffm |
2017-11-22 |
| SimLeap project–Bicoll: sweetener, 201711–2019 collab Bicoll is project partner |
2017-11-17 |
| SimLeap project–Charité: sweetener, 201711–2019 collab Charité is project partner |
2017-11-17 |
| SimLeap project–Germany (govt): grant, 201711–2019 BMB funding €1.1m out of total project volume of €1.6m |
2017-11-17 |
| SimLeap project–Symrise: sweetener, 201711–2019 collab Symrise is project partner |
2017-11-17 |
| High-Tech Gründerfonds–EWE: investment, 201711 € 7-figure investment in HTGF III fund by EWE AG |
2017-11-16 |
| Laboratoires Réunis–bio.logis: genetic software, 201711 supply use of bio.logis GIMS by Laboratoires Réunis |
2017-11-16 |
| Evotec–Leucadia: investor conference, 201711 supply service Evotec AG presents at Jefferies 2017 Global Healthcare Conference London |
2017-11-15 |
| 4SC–Stifel: investor conference, 201711 supply service 4SC presents at Stifel Nicolaus Healthcare Conference 2017 in NY |
2017-11-14 |
| Bayer–Loxo Oncology: TRK inhibitors, 201711– ww collab $400m upfront + $650m milestones developm of larotectinib + LOXO-195 |
2017-11-14 |
| Scipio Bioscience–High-Tech Gründerfonds: investment, 201711 seed financing round totalling €1.2m from Quadrivium 1 Seed Fund + HTGF |
2017-11-14 |
| Caris Life Sciences–Qiagen: lab automation equipment, 201711 supply QIAsymphony system to Caris Life Sciences |
2017-11-13 |
| CRISPR Therapeutics–CureVac: mRNA technology, 201711– collab + license using RNArt techn to develop in-vivo gene-editing programs in liver diseases |
2017-11-13 |
| Boehringer–MiNA Therapeutics: RNAa drugs, 201711– collab up to €307m plus royalties developm of RNAa drugs for fibrotic liver diseases incl NASH |
2017-11-08 |
| MiNA Therapeutics–MacDougall Biomedical Communications: public relations, 201711 service existent by MacDougall |
2017-11-08 |
| Nouscom–Life Sciences Partners: investment, 201711 financing round Series B totalling €42m incl returning co-investor LSP |
2017-11-06 |
| Boehringer–Dicerna Pharmaceuticals: RNAi drugs, 201711– collab up to $201m plus royalties developm of RNAi drugs for chronic liver diseases incl NASH |
2017-11-02 |
| Topas Therapeutics–Boehringer: investment, 201711 extension of financing round Series A to €18m with €4m investment from BIVF |
2017-11-02 |
| Charles River–Caprotec: CCMS technology, 2017 acquisition of CCMS IP + technology of Caprotec by Charles River |
2017-11-01 |
| Ada Health–SEVERAL: investment, 201710 financing round €40m led by Access Industries (Len Blavatnik) |
2017-10-31 |
| Blue Ocean Nova–Endress+Hauser: investment, 201710 acquisition €na of Blue Ocean Nova AG |
2017-10-31 |
| Boehringer–Hospital Corp of America: clinical research, 201710– collab expansion clinical developm combi cancer treatments w Sarah Cannon |
2017-10-30 |
| Daiichi Sankyo–Glycotope: antibody-drug conjugates, 201710– option agreem €na for license + collab using Daiichi ADC technology with PankoMab-GEX |
2017-10-30 |
| Heidelberg ImmunoTherapeutics–Akampion: public relations, 201710 service existent by Akampion |
2017-10-26 |
| Phenex–Akampion: public relations, 201710 service existent by Akampion |
2017-10-26 |
| Provecs–Akampion: public relations, 201710 service existent by Akampion |
2017-10-26 |
| Tesaro–Evotec: drug discovery services, 201710– collab 3y €na RnD small-molecule candidates against I/O target |
2017-10-26 |
| JnJ–BioMed X: pharma research, 201710– collab up to five research projects in area of autoimmune disease w Janssen RnD LLC |
2017-10-25 |
| Counsyl–Qiagen: genomic software tools, 201710 supply existent early customer of Qiagen Clinical Insight solution |
2017-10-19 |
| DCPrime–Apceth: contract manufacturing, 201710– supply service manufacturing of DCP-001 DC vaccine by Apceth Biopharma GmbH |
2017-10-19 |
| High-Tech Gründerfonds–RWE: investment, 201710 investment 7-digit € of RWE Generation SE in HTGF III Fund |
2017-10-19 |
| CureVac–Lilly: investment, 201710 equity investment $45m as part of mRNA cancer vaccines collaboration |
2017-10-18 |
| Lilly–CureVac: cancer vaccines, 201710– collab ww $50m upfront + $45m equity investment + $1.7b milestones up to 5 products using RNActive technology |
2017-10-18 |
| Weizmann Institute–Bruker: MRI system, 201710 supply Biospec 15.2 Tesla USR preclinical UHF MRI system |
2017-10-18 |
| Institut Nehring–Eurofins: investment, 201710 acquisition of Institut Nehring GmbH by Eurofins |
2017-10-16 |
| Apeiron–MC Services: public relations, 201710 service existent by MC Services AG |
2017-10-13 |
| InflaRx–Bain Capital: investment, 201710 financing round Series D totalling $30m incl co-lead investor Bain Capital Life Sciences LP |
2017-10-13 |
| InflaRx–Cormorant Asset Management: investment, 201710 financing round Series D totalling $30m incl co-lead investor Cormorant |
2017-10-13 |
| InflaRx–RA Capital: investment, 201710 financing round Series D totalling $30m incl co-lead investor RA Capital Management LLC |
2017-10-13 |
| InflaRx–SEVERAL: investment, 201710 financing round Series D $55m capital increase co-led by Bain Capital LS + Cormorant + RA Capital |
2017-10-13 |
| Medical Univ Innsbruck–Life Science-Stiftung: IP services, 201710– service collab knowledge + technology transfer with Ascenion GmbH |
2017-10-09 |
| Chiome Bioscience–Minapharm: GlymaxX technology, 201710– service + license cell line developm for antibody production applying GlymaxX by ProBioGen |
2017-10-05 |
| R-Biopharm–EuroProxima: research antibodies, 201710 acquisition of research antibody line from EuroProxima BV by Progen Biotechnik GmbH |
2017-10-05 |
| Boehringer–Siamab Therapeutics: antibody cancer drug, 201710– collab €na discovery of TACA selective targeting antibodies |
2017-10-04 |
| Immatics–Amgen: investment, 201710 financing round Series E totalling $58m incl Hopp + Strüngmann + Wellington Partners + Amgen et al |
2017-10-04 |
| Immatics–Hopp Group: investment, 201710 financing round Series E totalling $58m incl Hopp + Strüngmann + Wellington Partners + Amgen et al |
2017-10-04 |
| Immatics–SEVERAL: investment, 201710 financing round Series E $58m Hopp + Strüngmann + Wellington Partners + Amgen et al |
2017-10-04 |
| Immatics–Strüngmann Group: investment, 201710 financing round Series E totalling $58m incl Hopp + Strüngmann + Wellington Partners + Amgen et al |
2017-10-04 |
| Immatics–Wellington Partners: investment, 201710 financing round Series E totalling $58m incl Hopp + Strüngmann + Wellington Partners + Amgen et al |
2017-10-04 |
| Epiontis–Precision Medicine Group: investment, 201709 acquistion of Epiontis GmbH |
2017-09-30 |
| Eppendorf–Arburg: plastic moulding machine, 201709 supply of 100th Allrounder machine to Eppendorf Polymere GmbH |
2017-09-29 |
| Exscientia–Evotec: investment, 201709 investment €15m by Evotec AG to acquire minority stake in Exscientia Ltd |
2017-09-28 |
| Curetis–Ladenburg Thalmann: investor conference, 201709 supply service Curetis presents at Ladenburg Thalmann 2017 Healthcare Conference in NY |
2017-09-26 |
| Merlin Diagnostika–Bruker: investment, 201709 acquisition €na by Bruker |
2017-09-26 |
| Sonic Healthcare–Bruker: mass spectrometer, 201709 supply existent MLB is long-term user of MALDI Biotyper system |
2017-09-26 |
| BioNTech–Cantor Fitzgerald: investor conference, 201709 supply service BioNTech presents at Cantor Fitzegerald Global Healthcare Conference in NY |
2017-09-25 |
| Curetis–Cantor Fitzgerald: investor conference, 201709 supply service Curetis presents at Cantor Fitzegerald Global Healthcare Conference in NY |
2017-09-25 |
| Atriva Therapeutics–InSynchrony Ventures: investment, 201709 seed financing round 2nd tranche incl new investor InSynchrony Ventures |
2017-09-21 |
| Atriva Therapeutics–SEVERAL: investment, 201709 seed financing round 2nd tranche incl new investor InSynchrony Ventures |
2017-09-21 |
| Evotec–Baader Bank: investor conference, 201709 supply service Evotec attends Baader Investment Conference 2017 in Munich |
2017-09-20 |
| BioNTech–Akampion: public relations, 201709 service existent by Akampion |
2017-09-19 |
| Axiogenesis–Pluriomics: investment, 201709 merger into Ncardia |
2017-09-18 |
| Bruker–Bioinformatics Solutions: mass spectrometry software, 201709 collab existent using PEAKS Studio s/w for MS-based proteomics |
2017-09-18 |
| Bruker–Max Planck: mass spectrometry, –201709 collab developm of PASEF technology for timsTOF Pro MS for proteomics with Matthias Mann |
2017-09-18 |
| Evotec–Berenberg: investor conference, 201709 supply service Evotec presents at 6th German Corporate Conference in Munich |
2017-09-18 |
| Evotec–Goldman Sachs: investor conference, 201709 supply service Evotec presents at 7th Annual Biotech Symposium in London |
2017-09-18 |
| High-Tech Gründerfonds–Evonik: investment, 201709 investment existent in HTGF III fund |
2017-09-18 |
| Labiotech.eu–SEVERAL: investment, 201709 2nd financing round €6-digit led by Wille AG + incl Simon Bungers |
2017-09-18 |
| Labiotech.eu–Wille Finance: investment, 201709 2nd financing round totalling €6-digit incl new + lead investor Wille AG |
2017-09-18 |
| Numaferm–Evonik: investment, 201709 Evonik Venture Capital joins €7-digit seed financing round |
2017-09-18 |
| Evotec–Bank of America: investor conference, 201709 supply service Evotec presents at BoAML Global Healthcare Conference London |
2017-09-14 |
| Evotec–MaRS Innovation: drug discovery, 201709– collab partnership LAB150 for early-stage projects out of Canadian academic institutions |
2017-09-14 |
| Ginkgo Bioworks–Bayer: investment, 201709– founding joint venture firm with $100m Series A from Ginkgo + BLSC + Viking Global Investors |
2017-09-14 |
| Flagship Pioneering–Lipotype: lipid analysis, 201709c supply service lipid anaylsis for Flagship VentureLabs |
2017-09-13 |
| Bayer–Berkeley Lights: cell line development, 201709– collab using Beacon platform for cell line development + antibody discovery |
2017-09-12 |
| Ayoxxa–MC Services: public relations, 201709 service existent by MC Services AG |
2017-09-11 |
| Evotec–Morgan Stanley: investor conference, 201709 supply service Evotec presents at Morgan Stanley Global Healthcare Conference NY |
2017-09-11 |
| Curetis–Rodman & Renshaw: investor conference, 201709 supply service Curetis presents at Rodman & Renshaw Global Investment Conference in NY |
2017-09-10 |
| Epigenomics–Cathay Fortune: credit, 201709 convertible bonds €7.1m net €6.5m to Cathay Fortune |
2017-09-08 |
| BRAIN Biotech–Hopp Group: investment, 201709 capital increase 1.641m new shares placed with new investor DAH Beteiligungs GmbH |
2017-09-07 |
| BRAIN Biotech–Hopp Group: investment, 201709 capital increase €28m with 1.641m new shares at €18.055 to new investor DAH Beteiligungs GmbH |
2017-09-07 |
| Rigontec–Merck (US): investment, 201709– acquisition €115m cash upfront + €349m milestones |
2017-09-06 |
| Amal Therapeutics–Boehringer: investment, 201709 financing round Series B first closing totalling €8m incl co-lead investor BIVF |
2017-09-05 |
| Amal Therapeutics–High-Tech Gründerfonds: investment, 201709 financing round Series B first closing totalling €8m incl co-investor HTGF |
2017-09-05 |
| Immunic–SEVERAL: investment, 201709 financing round Series A extension €10m led by LSP bringing total Series A to €31.7m |
2017-09-05 |
| Metabolomic Discoveries–Metabolon: investment, 201709 acquisition €na of Metabolomic Discoveries GmbH by Metabolon Inc |
2017-09-05 |
| Pharnext–MC Services: public relations, 201709 service existent investor relations Europe by MC Services |
2017-09-05 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
